Interleukin 2 targeted therapy in inflammatory bowel disease.
Yarkoni
S
S
Sagiv
Y
Y
Kaminitz
A
A
Askenasy
N
N
D000818:Animals; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D007376:Interleukin-2 / Q000037:antagonists & inhibitors*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D007166:Immunosuppressive Agents; D007376:Interleukin-2